eicosapentaenoic acid ethyl ester has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arachidonic acid levels were moderately reduced but dihomogammalinolenic acid levels remained in the normal range." | 1.32 | The effects on plasma, red cell and platelet fatty acids of taking 12 g/day of ethyl-eicosapentaenoate for 16 months: dihomogammalinolenic, arachidonic and docosahexaenoic acids and relevance to Inuit metabolism. ( Fokkema, MR; Horrobin, D; Muskiet, FA, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horrobin, D | 1 |
| Fokkema, MR | 1 |
| Muskiet, FA | 1 |
1 other study available for eicosapentaenoic acid ethyl ester and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
The effects on plasma, red cell and platelet fatty acids of taking 12 g/day of ethyl-eicosapentaenoate for 16 months: dihomogammalinolenic, arachidonic and docosahexaenoic acids and relevance to Inuit metabolism.
Topics: 8,11,14-Eicosatrienoic Acid; Arachidonic Acid; Blood Platelets; Docosahexaenoic Acids; Dose-Response | 2003 |